Resmed Inc (NYSE:RMD) shares, rose in value on Friday, January 24, with the stock price up by 0.65% to the previous day’s close as strong demand from buyers drove the stock to $250.51.
Actively observing the price movement in the last trading, the stock closed the session at $248.88, falling within a range of $243.23 and $250.7. The value of beta (5-year monthly) was 0.687 whereas the PE ratio was 33.21 over 12-month period. Referring to stock’s 52-week performance, its high was $260.49, and the low was $170.56. On the whole, RMD has fluctuated by 5.58% over the past month.
With the market capitalization of Resmed Inc currently standing at about $36.77 billion, investors are eagerly awaiting this quarter’s results, scheduled for in February. The company’s Forward Dividend Ratio is 2.02, with its dividend yield at 0.81%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 5.11B, with a low estimate of 1.26B and a high estimate of 1.28B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.27B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RMD’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.43, with the price of RMD currently trading nearly 6.07% and 4.60% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 66.15, while the 7-day volatility ratio is showing 2.13% which for the 30-day chart, stands at 2.12%. Furthermore, Resmed Inc (RMD)’s beta value is 0.71, and its average true range (ATR) is 5.79.
A comparison of Resmed Inc (RMD) with its peers suggests the former has fared considerably weaker in the market. RMD showed an intraday change of 0.65% in last session, and over the past year, it grew by 43.17%%.
Data on historical trading for Resmed Inc (NYSE:RMD) indicates that the trading volumes over the past 10 days have averaged 0.83 and over the past 3 months, they’ve averaged 897.79K. According to company’s latest data on outstanding shares, there are 146.78 million shares outstanding.
Nearly 0.78% of Resmed Inc’s shares belong to company insiders and institutional investors own 61.64% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.91 million shares as on 2024-12-31, resulting in a short ratio of 10.63. According to the data, the short interest in Resmed Inc (RMD) stood at 620.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 7.54 million. The stock has risen by 9.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RMD stock heading into the next quarter.
